LONDON - Autolus Therapeutics plc (NASDAQ:AUTL), a biopharmaceutical company specializing in T cell therapies for cancer, has announced its participation in the upcoming 2025 Tandem Meetings | ...
highlighting the key strengths of Hong Kong's healthcare big data and its potential application in drug safety monitoring.' The research team is currently re-examining a wide range of potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback